Company · CIK 0001541157 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Akari Therapeutics Plc · AKTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 AForm 4 → | Aug 19, 5:00 pm EDT | Kameel D. FaragInterim CFO | 1,728 | $7.52 | $12,995 | 23,309 | — | |
| Jul 16, 2026 AForm 4 → | Aug 5, 6:30 pm EDT | Kameel D. FaragInterim CFO | 1,130 | $11.50 | $12,995 | 21,581 | — | late |
| Jul 7, 2026 MForm 4 → | Jul 17, 6:03 am EDT | Samir Rashmikant PatelDirector, 10% Owner | 22,474 | $0.4307 | $9,681 | 98,241 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 MForm 4 → | Jul 17, 6:03 am EDT | Samir Rashmikant PatelDirector, 10% Owner | 22,474 | $17.01 | $382,330 | 0 | — | late |